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INTRODUCTION
Epimorphic regeneration is the process that leads to full organ or
tissue replacement upon injury or amputation, characterized by
the generation of a transient structure called blastema (Morgan,
1901). The blastema is a crucial player in the regenerative
process and is composed of a pool of proliferative cells that are
responsible for the reconstitution of the lost tissue. This type of
tissue regeneration has been studied for decades in amphibian
and fish appendages; however, despite its major relevance to the
regenerative capacity, blastemal cell origin has remained unclear
(Kawakami, 2009).
In adult zebrafish, the amputation of the caudal fin leads to a
succession of steps (wound healing, blastema formation and
regenerative outgrowth) that restore the various tissues of the fin,
including blood vessels, nerves, connective tissue, epidermis,
pigment cells and lepidotrichia, the skeletal elements that support
the fin structure. Lepidotrichia are elongated bony rays of dermal
origin that run from proximal to distal in the caudal fin (Akimenko
et al., 2003). Each lepidotrichia is composed of concave and
opposed hemirays with intra-ray mesenchymal tissue (Montes et
al., 1982). The caudal fin skeletal tissue is laid down by
scleroblasts, skeletogenic cells equivalent to mammalian
osteoblasts that secrete the lepidotrichia matrix (Hall, 2005).
It has been hypothesised that upon amputation of the adult
zebrafish caudal fin, bony ray regeneration arises from the intra-
ray mesenchymal cells that become disorganized, change their
shape, re-enter the cell cycle and migrate distally (Nechiporuk
and Keating, 2002; Poleo et al., 2001; Santos-Ruiz et al., 2002).
This intra-ray mesenchyme is thought to contain pluripotent,
stem or progenitor cells that are activated upon amputation and
participate in the formation of the blastema and subsequent
tissue regeneration (Nakatani et al., 2008). The existence of this
type of cells was, however, challenged by Nechiporuk and
Keating (Nechiporuk and Keating, 2002). In an attempt to mark
such stem cells, these authors observed that BrdU-retaining cells
are not a major component of the blastema. Indeed, so far, only
pigment cells have been proposed to arise from a population of
stem cells distributed along the intra-ray tissue (Rawls and
Johnson, 2000). An alternative hypothesis is that the blastema
is a pool of cells originating from different mature tissues that
undergo dedifferentiation and integrate into the blastema, as
demonstrated for muscle fibres in the regenerating tail of
urodele amphibians (Echeverri et al., 2001; Straube and Tanaka,
2006). In this scenario, the blastema is composed of a
heterogeneous pool of lineage restricted progenitor cells (Kragl
et al., 2009). Lepidotrichia regeneration has been reported to
start after blastema formation (24-48 hours post-amputation;
hpa), as a patterning mechanism beginning at 72 hpa when
blastemal cells receive patterning signals from the basal layer
of the epidermis, leave the blastema and integrate into the
population of scleroblasts that align at the stump to secrete
lepidotrichia matrix (Nechiporuk and Keating, 2002; Smith et
al., 2006).
In this study, we have sought to define how early the process
of lepidotrichia regeneration is initiated in the zebrafish caudal
fin, and to identify the origin of cells that contribute to the
blastema during regeneration. In light of the two current
hypotheses, we have explored the possibility that differentiated
skeletal cells contribute to fin regeneration. We provide evidence
that differentiated scleroblasts from the bony ray lining re-enter
the cell cycle, detach from the lepidotrichia surface, migrate
distally, integrate into the blastema and dedifferentiate. These
findings highlight the contribution of differentiated scleroblasts
to epimorphic appendage regeneration in zebrafish.
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SUMMARY
The origin of cells that generate the blastema following appendage amputation has been a long-standing question in epimorphic
regeneration studies. The blastema is thought to originate from either stem (or progenitor) cells or differentiated cells of various
tissues that undergo dedifferentiation. Here, we investigate the origin of cells that contribute to the regeneration of zebrafish
caudal fin skeletal elements. We provide evidence that the process of lepidotrichia (bony rays) regeneration is initiated as early as
24 hours post-amputation and that differentiated scleroblasts acquire a proliferative state, detach from the lepidotrichia surface,
migrate distally, integrate into the blastema and dedifferentiate. These findings provide novel insights into the origin of cells in
epimorphic appendage regeneration in zebrafish and suggest conservation of regeneration mechanisms between fish and
amphibians.
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Fish manipulation and amputation
Wild-type AB strain adult zebrafish, Danio rerio (3- to 6-months old) were
anaesthetised in 0.1% MS-222 (Sigma) and the caudal fins amputated using
a scalpel. Regeneration was then allowed to proceed until defined time
points at 33°C. Fish were then anaesthetised and regenerates were collected
for analysis.
Whole-mount in situ hybridisation
Fins were fixed overnight in 4% paraformaldeyde (PFA) in phosphate
buffered saline (PBS), dehydrated in ethanol at room temperature (RT) and
stored at –20°C at least overnight. Fins were then rehydrated in an ethanol-
PBS plus 0.1% Tween 20; PBT) series. A solution of 6% H2O2 in PBT was
used for 30 minutes to inactivate endogenous peroxidases, followed by
washes in PBT. Proteinase K (10 mg/ml) digestion was performed for 15
minutes and then stopped by washing with a glycine solution (2 mg/ml in
PBT). After a brief wash in PBT, fins were refixed with 3.7%
formaldehyde solution, 0.2% glutaraldehyde in PBT for 20 minutes, and
then washed with PBT. Fins were prehybridised for >1 hour at 70°C, in
hybridisation solution (Hyb solution) containing 60% formamide, 5 SSC
(20, pH 6.0), 500 g/ml tRNA, 0.1% Tween 20 (10%), 50 g/ml heparin,
in miliQ H2O. Fins were then hybridised in Hyb solution, containing 5
l/ml digoxigenin (DIG)-labelled RNA probe, overnight at 70°C. The next
day, unhybridised probe was removed using washing solutions I and II
(washing solution I: formamide 50%, 1 SCC, 0.1% Tween 20; washing
solution II: 50% wash I, 50% Tris-buffered saline plus 0.1% Tween 20;
TBST) at 70°C for 15-30 minutes (wash I: 215 minutes + 230 minutes;
wash II: 220 minutes). Fins were then washed with TBST, incubated with
blocking solution (10% sheep serum in TBST) at RT for several hours, and
then incubated with anti-digoxigenin antibody coupled to alkaline
phosphatase (Roche) 1:2500 in blocking solution, overnight, at 4°C. The
anti-digoxigenin antibody was removed by several washes with TBST. For
the alkaline phosphatase reaction, fins were washed in three changes of
NTMT reaction buffer (5 M NaCl, 1 M Tris-HCl pH 9.5, 1 M MgCl2, 10%
Tween 20, in H2O MQ). In situ hybridisations were stained with Purple AP
Substrate (Roche).
DIG-labelled antisense RNA probes for all studied genes were
synthesised as previously described by Henrique et al. (Henrique et al.,
1995). For cross sections, fins were embedded in gelatin, processed using
standard conditions and sectioned (10-14 m) using a cryostat (Leica). In
situ hybridisation on cryosections was performed as described by Smith et
al. (Smith et al., 2008). Details for RNA probes for sox9a, osterix (sp7 –
Zebrafish Information Network), col1a2 and col10a1 genes were described
by Li et al. (Li et al., 2009).
Immunohistochemistry
The fins were fixed in a solution of 80% methanol, 20% DMSO (Sigma).
For whole-mount specimens, the fins were rehydrated in a methanol-PBS
series, permeabilised with acetone at –20°C for 20 minutes, followed by
two washes in PBS. An additional permeabilisation step was carried out
with a PBST 0.5% solution (PBS with 0.5% Triton X-100) for 30 minutes.
Fins were then washed several times with PBS, blocked in PBS with 10%
foetal bovine serum (FBS) and incubated with primary antibody overnight
at 4°C. The next day, fins were washed several times in PBS and incubated
with the secondary antibody overnight at 4°C. They were then mounted for
analysis. For cryostat sections, fins were fixed in 80% methanol, 20%
DMSO (Sigma) or 4% PFA-PBS, and processed. Sections were washed
twice in PBS at 37°C for 10 minutes, followed by a glycine (0.1 M) wash
for 10 minutes at RT. The permeabilisation was carried out with PBST
0.5% for 20 minutes at RT. Following several washes in PBS, sections
were blocked in 0.3% PBST with 0.25% BSA (Sigma), and incubated with
primary antibody overnight at 4°C. After primary antibody binding,
samples were washed three times in PBS for 5 minutes. Appropriate
secondary antibodies were diluted in blocking solution and incubated
overnight at 4°C. All sections were counterstained with 0.15% (w/v) 4,6-
diamidino-2-phenylindole (DAPI; Sigma) for 5 minutes, washed three
times in PBS for 5 minutes and mounted for analysis. The primary
antibodies used were the monoclonal anti-Zns5 antibody to mark
scleroblasts (ZIRC 011604), anti-Osteocalcin antibody described by Simes
et al., anti-PCNA antibody to label cell proliferation (F2007; Santa Cruz
Biotech), anti-GFP antibody (Abcam) and anti-Msxb antibody (4G1-c;
Hybridoma Bank) (Simes et al., 2004). For simultaneous detection of
osterix mRNA and osteocalcin:GFP (osteocalcin is also known as bglap –
Zebrafish Information Network), a anti-GFP antibody (ab290; Abcam) was
added following in situ hybridisation, in which the alkaline phosphatase
(AP) substrate was Fast Red (Roche).
Zebrafish transgenic lines
The transgenic line used for cell tracing experiments was Tg(eab2:EGFP-
T-mCherry) crossed with Tg(osteocalcin:GFP). These lines were kindly
provided by Wenbiao Chen (Vollum Institute, Oregon Health and Sciences
University, Portland, USA) [described by Boniface et al. (Boniface et al.,
2009)] and Stefan Shulter-Merker (Hubrecht Institute-KNAW and
University Medical Centre, Uppsalalaan 8, 3584 CT Utrecht, The
Netherlands), respectively. The transgenic line Tg(osteocalcin:GFP) was
also crossed with Tg(osterix:mCherry), as described by Spoorendonk et al.
(Spoorendonk et al., 2008).
Cell labelling and tracing
The pCS2-Cre plasmid (provided by Thomas Look) [described by
Langenau et al. (Langenau et al., 2005)] was digested with NotI, and the
linear template was transcribed using the mMESSAGE mMACHINE High
Yield Capped RNA Transcription Kit (Ambion). Double transgenic
embryos Tg(eab2:EGFP-T-mCherry; osteocalcin:GFP) were injected with
synthetic Cre mRNA (100 ng in 1.4 nl) at the 1- to 2-cell stage to create
mosaics clones. A PV-820 Picoinjector (World Precision Instruments) and
a Narashige micromanipulator were used for microinjection. Embryos were
left to grow at 28°C until adulthood. Fins of double transgenic adult fish
aged 3 months old were amputated and regeneration was followed at
different time points. The sequential images are always of the ray of the
same transgenic fish. For the shorter time-lapse experiment the anaesthesia
was prepared as described in Huang et al. (Huang et al., 2010). The fish
were anaesthetised with the MS-222 (Sigma) for ~3 minutes before the
addition of the mixture of MS-222 and isoflurane, which was used during
the time-lapse confocal imaging. The images were analysed with the
ImageJ ‘StackReg’ plugin and some cells were coloured for better
identification of their shape and position.
Microscopy
Images of in situ hybridisation were obtained with a Leica Z6APO
stereomicroscope equipped with a Leica DFC490 digital camera. For cell
number analysis and cell tracing experiments in transgenic lines, images
were captured on a Zeiss LSM 510 META confocal microscope or a Zeiss
LSM 710 confocal microscope. The stacks were analysed and cells counted
using ImageJ software. In experiments in which cells were counted, a
minimum of three different individuals for each condition were analysed.
The plots were obtained and statistically analysed with GraphPad Prism
software.
Total RNA isolation and quantitative gene expression analysis
Total RNA was extracted from regenerating fins, including the first bony
ray segment and the blastema tissue (five fins per extraction) as described
by Chomczynski and Sacchi (Chomczynski and Sacchi, 1987) and was
then treated with RQ1 DNase (Promega) according to the manufacturer’s
protocol. RNA quantity and quality was determined by UV absorbance
and electophoresis. cDNA was then prepared from 1 g of total RNA
from each sample using Moloney-murine leukemia virus (M-MLV)
reverse transcriptase (Invitrogen), RNase Out (Invitrogen) and an
oligo(dT) adapter [5-ACGCGTCGACCTCGAGATCGATG(T)13-3] in
a 20 l volume for 1 hour at 37°C. For quantitative real-time PCR a
StepOnePlus 96 (Applied Biosystems) was used together with 1
SsoFastTM EvaGreen Supermix (Bio-Rad), 0.2 M forward and reverse
primers and 100 ng of reverse-transcribed RNA under the following PCR
conditions: 15 minutes at 95°C, 40-50 cycles (each cycle was 30 seconds
at 95°C, 15 seconds at 68°C). Gel electrophoresis and melt curve analysis
were used to confirm specific product formation. Data were statistically
analysed using the Kruskal-Wallis test followed by the non-parametric











paired Wilcoxon post-hoc t-test. All the values were significantly
different from the uncut control, with a P-value <0.05, except when
indicated in the respective figure legend.
RESULTS
Prompt activation of skeletogenesis genes reveals
an early onset of lepidotrichia regeneration
From expression studies of skeletogenesis genes at 72 and 96 hpa
(Smith et al., 2006; Smith et al., 2008; Brown et al., 2009) it is
thought that during caudal fin regeneration lepidotrichia
regeneration starts after the blastema formation. However, gene
expression analysis at earlier phases has never been done
systematically. In order to refine the timing of lepidotrichia
regeneration onset we performed a comprehensive expression
analysis of the genes that are classically associated with vertebrate
bone formation at earlier stages of regeneration, from 12 to 72 hpa
by in situ hybridisation (ISH). The genes studied include the early
skeletogenesis markers sox9a and osterix, markers of the
intermediate stages of skeletogenesis (bone matrix deposition
stages) col1a2 and col10a1, and also late differentiation markers
involved in mineralisation, osteonectin (sparc – Zebrafish
Information Network) and osteocalcin (bglap – Zebrafish
Information Network) (Fig. 1). We found that sox9a was
upregulated at 12 and 24 hpa within the bony rays (Fig. 1A,B) and
was also detected in the blastema at 48 and 72 hpa (Fig. 1C,D). At
48 hpa, sox9a was detected specifically in both the intra-ray
mesenchyme and the basal layer of the epidermis (see Fig. S1A in
the supplementary material). osterix, the expression of which marks
osteoblast progenitors, was first detected at 24 hpa (Fig. 1E,F), at
the blastema. This expression domain was maintained at 48 and 72
hpa (Fig. 1G,H) to include a strong expression domain at 72 hpa
where scleroblasts align to form the regenerated lepidotrichia (Fig.
1H). Indeed, osterix was detected at the site where the first
scleroblasts align, just distal to the amputation site, as early as 48
hpa (see Fig. S1B in the supplementary material). Also col1a2 and
col10a1 expression was not detectable at 12 hpa (Fig. 1I,M),
whereas from 24 to 72 hpa, expression of both genes was strongly
detected within the blastema (Fig. 1J-L,N-P). Interestingly, col1a2
mRNA, a collagen type generally associated with bone matrix
formation, was distributed throughout the blastema at 48 hpa (see
Fig. S1C in the supplementary material), including the mesenchyme
of the blastema. By contrast, the col10a1 expression domain was
restricted to the aligning scleroblasts just distal to the amputation
plane of the bony ray (see Fig. S1D in the supplementary material).
It is also noteworthy that at 72 hpa, col10a1 expression was
restricted to the ray domains of the blastema, whereas col1a2
mRNA had a more widespread distribution in the blastema,
including the inter-ray domain (Fig. 1L,P). Similarly, osteonectin, a
gene that encodes a bone matrix protein, was also not present at 12
hpa (Fig. 1Q), being just detected at 24 hpa at the amputation site
(Fig. 1R). Later, at 48 and 72 hpa (Fig. 1S,T), the expression of
osteonectin was also detected at high levels just distal to the
amputation site, similar to that of osterix (compare Fig. 1H and 1T).
osteocalcin, a gene that also encodes a bone matrix protein, was not
present at 12 hpa (Fig. 1U) and was weakly detected at 24 and 48
hpa (Fig. 1V,W). At 72 hpa (Fig. 1X) osteocalcin was present within
the bony rays and just distal to the amputation plane where
mineralization is occurring at this stage. In the distal portion of
uncut samples all the analysed genes had undetectable or very low
expression. (Fig. 1D,H,L,P,T,X). In particular, expression of
osterix and col10a1 could be detected at the most distal tip of the
fin, where the fin is slowly but continuously growing.
Together, these data show that expression of skeletogenesis
genes is strongly upregulated during the initial stages of caudal fin
regeneration in the adult zebrafish and suggest that the process of
lepidotrichia regeneration is initiated as early as 24 hpa.
Skeletal cells are present during early stages of
bone regeneration
Following our in situ hybridisation analysis that suggested that the
process of lepidotrichia regeneration starts at 24 hpa, we wanted to
know whether skeletal cells were actually present at those early
stages of regeneration. To mark these cells we took advantage of the
Zns5 antibody, which is widely used to label scleroblasts at various
stages of differentiation (Johnson and Weston, 1995). To identify the
domains marked by Zns5, we carried out a detailed analysis by
immunohistochemistry on whole mounts and cross sections of uncut,
24 and 48 hpa regenerating fins. We found that Zns5 stained bone
lining scleroblasts (BLS) at all stages studied (Fig. 2), including
uncut samples (Fig. 2A,B). At 24 hpa, the expression of Zns5 was
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Fig. 1. Expression of skeletogenesis genes during early stages of
caudal fin regeneration. (A-X) Whole-mount in situ hybridisation of
(A-D) sox9a, (E-H) osterix, (I-L) col1a2, (M-P) col10a1, (Q-T)
osteonectin and (U-X) osteocalcin at 12, 24, 48 and 72 hpa and in
uncut specimens in the distal region of the fin. Scale bars: 100m in













also seen in the earliest aligning scleroblasts (AS) located just distal
to the amputation site of the bony ray (Fig. 2C,D). At 48 hpa, there
was an increase in the number of aligning scleroblasts compared with
24 hpa (Fig. 2E,F). These data provide evidence that scleroblast
alignment is initiated as early as 24 hpa.
Differentiated scleroblasts proliferate during
lepidotrichia regeneration
In order to investigate how early bone tissues proliferate in response
to amputation we assessed the expression of proliferating cell nuclear
antigen (PCNA) in Zns5-positive cells at 24 hpa. Our
immunohistochemistry data showed that cell proliferation was
sporadic in the epidermis of the uncut samples and was detected at
very low levels in BLSs (Fig. 3A,B). However, cell proliferation was
strongly enhanced in BLSs at 24 hpa to over 30% of all cells of each
subtype (Fig. 3C-E). Interestingly, at 24 hpa the AS population
proliferated at a similar rate to the BLS population (Fig. 3C-E).
To further characterise the pattern of cell division in
differentiated scleroblasts upon amputation of the caudal fin, we
have analysed the proliferative state of the osteocalcin-expressing
scleroblasts by immunohistochemistry in whole-mount samples.
We used a transgenic zebrafish line that expressed GFP under the
control of an osteocalcin promoter (see Materials and methods for
further details), and found that osteocalcin-expressing scleroblasts
do not express PCNA before amputation (Fig. 3F,G). However, at
24 hpa osteocalcin-expressing BLSs accounted for over 60% of all
osteocalcin-expressing cells (Fig. 3H-J). Moreover, we also found
osteocalcin-expressing cells at the blastema compartment that were
positive for both GFP and PCNA, accounting for ~40% of all
osteocalcin-expressing cells at the blastema (Fig. 3H-J). These data
provide further evidence that BLSs, which are differentiated
scleroblasts, acquire a proliferative state upon amputation of the
caudal fin.
In summary, we show that osteocalcin-expressing BLSs acquire
a striking proliferative pattern upon amputation and that
osteocalcin-expressing cells are also present at the blastema, thus
implicating this cell population as a potential player in the blastema
formation process.
Differentiated scleroblasts migrate to the blastema
Next, we decided to focus our efforts on tracking differentiated cells
that were located in the bone lining of the lepidotrichia to check
whether, upon amputation, they migrate from their location to
participate in the regeneration of the ray. We used an osteocalcin-
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Fig. 2. Zns5 expression domains during early stages of fin
regeneration. (A-F)Immunostaining with Zns5 antibody in (A,C,E)
whole mount and (B,D,F) longitudinal cryosections of (A,B) uncut, (C,D)
24 hpa, (E,F) 48 hpa fins. The arrowhead in C indicates Zns5-positive
cells at the blastema. The arrows in D and F indicate aligning
scleroblasts. Scale bar: 50m (45m in B). Dashed lines indicate
amputation plane.
Fig. 3. Proliferation of bone-lining cells increases upon
amputation of the caudal fin. (A-D)Double immunohistochemistry
with PCNA and Zns5 antibody in wild-type fins. (A,B)Uncut and (C,D)
24 hpa fins. (A,C)Zns5 (green) and PCNA (red). (B,D)Zns5 (green),
PCNA (red) and DAPI (blue). The arrow in A indicates an proliferating
epidermal cell. The arrowheads in C indicate proliferating BLSs and the
arrows indicate aligning proliferating scleroblasts. (E)Percentage of the
total Zns5-positive cells that were also positive for PCNA in the BLS and
AS populations, calculated for the first segment below and above the
amputation plane at 24 hpa, and in the equivalent region of uncut fins.
There was a significant increase in double-positive BLSs in the 24 hpa
samples compared with uncut samples (Student’s t-test, P<0.05; n5
for each condition). (F-I)Double immunohistochemistry with GFP and
PCNA antibody in Tg(osteocalcin:GFP) fins. (F,G)Uncut fin. (H,I)24 hpa
fin. (F,H)osteocalcin:GFP (green) and PCNA (red). (G,I)osteocalcin:GFP
(green), PCNA (red) and DAPI (blue). In H, the arrow indicates a
proliferating osteocalcin-expressing cell within the blastema; the
arrowhead indicates a proliferating osteocalcin-expressing BLS.
(J)Percentage of cells double-positive for osteocalcin:GFP and PCNA
over the total osteocalcin:GFP-positive cells, in the BLS and blastema
populations, calculated for the first segment below and above the
amputation plane at 24 hpa, and in the equivalent region of uncut fins.
There was a significant increase in double-positive BLSs in the 24 hpa
samples compared with uncut samples (Student’s t-test, P<0.05; n5-8
for each condition). Scale bar: 100m in A,B,F-I and 75m in C,D.











expressing reporter line because this gene is a late skeletogenesis
marker that is present in differentiated scleroblasts. In uncut samples,
osteocalcin was strongly detected throughout the internal bone lining
of all hemiray segments analysed, except at the joint level (Fig. 4A).
At 24 hpa, osteocalcin reporter cells were seen not only at the bone
lining but also at the blastemal compartment, representing ~10% of
the blastema cell population (Fig. 4B,E,I). At 30 and 48 hpa, the
number of osteocalcin reporter cells at the blastema was reduced to
~5% of all blastema cells (Fig. 4G-I).
Interestingly, at 24 hpa osteocalcin BLSs appeared to detach
from the bone surface as their number seemed to decrease in the
vicinity of the amputation plane (Fig. 4B, arrowhead). This was
accompanied by a change in their shape from elongated in the
uncut samples (Fig. 4C,D) to more rounded at 24 hpa (Fig. 4E,F).
Together these data suggest that osteocalcin BLSs migrate distally.
To further assess this observation and to demonstrate that it is very
unlikely that these GFP-positive cells arise from any other cell type
that eventually starts to activate osteocalcin expression, we
searched for the presence of osteocalcin:GFP by in situ
hybridisation in the regenerating fins at 24 and 48 hpa. We did not
find any de novo transcriptional activation of the transgene at the
blastema region, when compared with the proximal region of the
uncut fin (see Fig. S2A-C in the supplementary material), thus
indicating that GFP-positive cells at the blastema are those that
have migrated from the bone lining.
To further test the hypothesis of differentiated scleroblast
migration we used a double transgenic approach to allow in vivo
tracking of individual scleroblasts. The first transgene labels
differentiated scleroblasts by expressing GFP under the control of an
osteocalcin promoter (Fig. 5A-F). The second transgene expresses
GFP under the control of a ubiquitous promoter, but its expression
can be switched to mCherry by the activity of Cre recombinase (see
Materials and methods) (Boniface et al., 2009). The injection of Cre
recombinase mRNA during embryonic development creates mosaic
embryos, in which some cells change their reporter expression.
During adulthood, all GFP-expressing cells that have recombined
and express mCherry will not express GFP any longer under the
control of the constitutive promoter (Boniface et al., 2009). This
technique generates a low number of mCherry-expressing cells, the
position of which can be tracked both before and after amputation of
the caudal fin. Because some mCherry-expressing cells will be
positive for the osteocalcin:GFP transgene, they are seen as yellow.
By tracking these yellow scleroblasts in vivo in the same ray of the
same animal at different time points, we have been able to trace their
fate after amputation of the caudal fin.
Before fin amputation, we identified the yellow cells to be
tracked (Fig. 5A), and then followed them live, starting at 12 hpa
(Fig. 5B-E). We observe that osteocalcin-positive cells localized in
the bone lining near the amputation site at 12 hpa (Fig. 5B) were
present in the blastema at 24 hpa (Fig. 5C), showing that
differentiated scleroblasts migrate into the mesenchymal pool of
blastema cells. Note that up to 48 hpa the yellow cells present in
the blastema did not express osteocalcin:GFP de novo (see Fig.
S2A-C in the supplementary material) so they must originate from
the bone lining. Gradually, from 24 to 34 hpa the yellow cells
turned red, which indicates downregulation of the osteocalcin
transgene (Fig. 5C-E), and suggests that scleroblasts arising from
the bone lining were losing one of their differentiation markers. To
further confirm the hypothesis that osteocalcin is downregulated,
we performed quantitative PCR (qPCR) to quantify the levels of
osteocalcin mRNA from 12 to 96 hpa Our qPCR data show that
osteocalcin mRNA decreases from 12 to 48 hpa as compared with
the levels in uncut fins (Fig. 5G). By contrast, from 48 to 96 hpa,
osteocalcin mRNA levels progressively increased relatively to the
uncut controls (Fig. 5G). This indicates that scleroblasts that
migrate to the blastema completely lose osteocalcin expression by
48 hpa and that later, at 72 hpa, new bone cells start to express
osteocalcin, because the yellow labelling reappeared in the aligning
scleroblasts (Fig. 5G; see Fig. S3 in the supplementary material).
To provide additional evidence that osteocalcin-positive cells
can move towards the blastema from 12 to 24 hpa, we performed
in vivo imaging of osteocalcin:GFP transgenic fish using shorter
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Fig. 4. Presence of GFP-positive osteocalcin-reporter cells in the
blastema upon amputation of the caudal fin. (A,B)osteocalcin-
reporter expression in Tg(osteocalcin:GFP) fins. (A)Uncut fin. (B)24 hpa
fin. The arrow indicates osteocalcin-expressing cells at the blastema and
the arrowhead indicates the lack of the osteocalcin reporter expression.
(C-H)Immunohistochemistry for GFP in Tg(osteocalcin:GFP) fins.
(C,D)Uncut fin. (E,F)24 hpa fin. The arrow indicates osteocalcin-
expressing cell in the blastema. D and F are magnified optical slices of C
and E, respectively. (G)30 hpa fin. (H)48 hpa fin. (I)Percentage of
osteocalcin:GFP-expressing cells over the total DAPI-stained nuclei in
the blastema population. There were significantly fewer
osteocalcin:GFP-expressing cells at 30 and 48 hpa than at 24 hpa
(Student’s t-test, P<0.05; n11-13 for each condition). Scale bar:
115m in A; 100m in B; 50m in C,E,G,H; 20m in D and F. Dashed












imaging intervals, which, because of phototoxicity, could not be
shorter than 20 minutes. This led us to the identification of 19-21
hpa as the crucial time when the scleroblast movement is initiated.
We tracked osteocalcin:GFP BLSs, starting at 19 hpa when these
cells were at the bone lining (Fig. 5H) and followed their
movement to the newly formed blastema (Fig. 5H-M; see Movie 1
in the supplementary material). To facilitate visualization we have
colour coded (green) two examples of individual cells where cell
shape changes and movement to the blastema is clear. Interestingly,
in this sequence of images it is also possible to see an
osteocalcin:GFP cell dividing (Fig. 5J, arrow). In uncut fins we
never observed any significant movement of osteocalcin:GFP cells
(see Movie 2 in the supplementary material). These results provide
compelling evidence that osteocalcin-expressing BLSs are able to
detach from the bone lining and migrate towards the blastema.
Scleroblasts dedifferentiate
The qPCR data indicated that osteocalcin was downregulated from
12 to 48 hpa (Fig. 5G); however, the protein was still present at 24
hpa because Osteocalcin-expressing cells were seen at the blastema
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Fig. 5. Differentiated scleroblasts from bone lining migrate to integrate in the blastema. (A-E)In vivo confocal images from a double
transgenic Tg(eab2:EGFP-T-mCherry; osteocalcin:GFP) fish, injected with Cre mRNA. (A)Uncut fin; the arrows indicate yellow cells in the bone lining
to be tracked upon amputation. (B)12 hpa fin, the arrows indicate tracked yellow cells in the lining of the bone that have become rounder,
indicative of their proliferative state. (C)24 hpa fin; the yellow cells have migrated from the bone lining to the blastema. (D)30 hpa fin. (E)34 hpa
fin. In D and E, the arrows mark yellow cells that progressively lose GFP expression driven by the osteocalcin promoter and expresses only mCherry.
The sequential images (B-F) were taken from the same ray of the same transgenic fish, in total we tracked five animals. The images are a projection
of several confocal optical slices. Scale bar: 50m in all images. Dashed lines indicate amputation plane. (F)A diagram showing the different
possible outcomes of a cell from a double transgenic fish, Tg(eab2:EGFP-T-mCherry; osteocalcin:GFP) injected with Cre mRNA. An osteocalcin:GFP-
positive cell in which the switchable marker (eab2:EGFP-T-mCherry) has not been activated is seen as a green cell. However, with the activation, the
osteocalcin:GFP-positive cell also expresses mCherry, and is seen as yellow. Then, if the osteocalcin:GFP expression is downregulated the yellow cell
can be seen as red. This red cell can turn yellow again when osteocalcin:GFP is re-expressed at 72 hpa (G)qPCR shows that at 12-48 hpa
osteocalcin expression decreases compared with uncut fins and that at 72 and 96 hpa this expression increases sixfold and 23-fold, respectively
(P<0.05, n6 for each condition). (H-M)In vivo imaging of Tg(osteocalcin:GFP) from 19 to 20.5 hpa. The interval between each frame is 20
minutes. (H)A single ostecalcin-positive cell, artificially coloured green, is tracked in the subsequent images, I-M (in H the position of this cell was
not clear). It is possible to see the cell extending protrusions, changing shape and migrating to integrate in the blastema. Another osteocalcin-
positive cell at the bone lining is identified in I and is tracked in sequential images, J-M. The arrow in J indicates a proliferating osteocalcin-positive











(see Fig. S4 in the supplementary material). To analyse further the
state of differentiation of the osteocalcin reporter cells at the blastema
we looked for osterix expression in these cells. osterix, a transcription
factor present in early committed scleroblasts, was expressed at the
distal tip of the uncut samples (see Fig. S2D in the supplementary
material), whereas near the amputation zone it was detected at very
low levels, making it difficult to find double-positive cells for
osteocalcin and osterix in uncut samples (Fig. 6A,D). At 24 hpa the
number of cells positive for both osteocalcin and osterix was not
significantly different from that of uncut samples (Fig. 6D).
Sporadically, we found double-positive cells at the blastema, in
agreement with the expression level of the osterix:mCherry mRNA
at this time-point (Fig. 6B,D; see Fig. S2E in the supplementary
material). However, the number of double-positive cells, as well as
the osterix:mCherry mRNA, increased significantly at 48 hpa (Fig.
6C,D; see Fig. S2F in the supplementary material). At this time-point
the population of double-positive cells represented almost 80% of all
osteocalcin-expressing cells at the blastema, a significant increase
compared with the numbers at 24 hpa and in uncut samples (Fig.
6C,D). We performed in situ hybridisation followed by
immunohistochemistry to further confirm the re-expression of osterix
mRNA by dedifferentiating osteocalcin-expressing cells at the
blastema (see Fig. S5 in the supplementary material). Taken together
these data support the view that differentiated scleroblasts
dedifferentiate at the blastema; they lose osteocalcin expression and
start to re-express osterix, an early marker of committed scleroblasts.
We also investigated whether these cells can revert to a fully
undifferentiated state by testing co-expression of msxb, a
transcription factor implicated in the maintenance undifferentiated
cells (Odelberg et al., 2000; Song et al., 1992; Nechiporuk et al.,
2002). In uncut samples, there was no Msxb (see Fig. S6A,B in the
supplementary material). At 48 hpa, while the cells were
dedifferentiating, Msxb-positive cells were present at the blastema
but we did not find any colocalisation with osteocalcin-expressing
cells (see Fig. S6C,D in the supplementary material).
DISCUSSION
Appendage regeneration in fish has been intensively studied in the
last decades; however, the origin of the blastema has remained
elusive. Two different possible sources for these cells have been
proposed: dedifferentiation of mature cells or activation of
quiescent progenitors or stem cells (Kawakami, 2009). Here, we
focused on the earliest stages of regeneration to address the
potential contribution of differentiated scleroblasts to the blastema.
We provide evidence that upon amputation, these differentiated
bone cells acquire a proliferative state and migrate distally to
integrate with the blastema and dedifferentiate.
Lepidotrichia regeneration is initiated as early as
24 hpa in adult zebrafish caudal fin
Previous bone regeneration studies in the caudal fin have been
mainly limited to regenerative outgrowth stages, i.e. from 72 hpa
onwards (Smith et al., 2006; Smith et al., 2008; Brown et al.,
2009). The gene expression analysis at early stages of fin
regeneration presented here reveals that some of the genes that
specify skeletal lineages are present as early as 24 hpa. In the case
of sox9a the expression starts even earlier, as it was detected at 12
hpa in the intra-ray mesenchyme. This expression is, at first glance,
surprising as it is normally associated with cartilage differentiation
(Yan et al., 2002; Grandel and Schulte-Merker, 1998). However,
the caudal fin rays are dermal bone (Geraudie and Landis, 1982;
Santamaria et al., 1992) and are an example of a skeletal tissue in
which chondrocyte markers, such as sox9a, are expressed (Smith
et al., 2006). It is possible that the expression of sox9a in the intra-
ray mesenchyme may indicate another source of skeletal progenitor
cells that could contribute to regeneration; a hypothesis that we
have not explored in this work.
In order to study in more detail the localisation of skeletal cells
during the earliest stages of bony ray regeneration, we conducted
immunohistochemistry with the Zns5 antibody, widely used to
detect scleroblasts (Johnson and Weston, 1995). We found that
Zns5 stained not only BLSs, but also ASs, which are localised just
proximal to the stump, from 24 hpa onwards. We conclude from
our molecular and cellular analysis that the lepidotrichia
regeneration process is initiated no later than 24 hpa and that at 72
hpa the bone cells are already ongoing differentiation.
Differentiated scleroblasts near the stump acquire
a proliferative state, change shape, migrate into
the blastema and dedifferentiate
The regeneration of the fin rays implies a significant re-growth of
bone tissue. In order to analyse the proliferative state of skeletal cells
we performed double immunostainings with the cell proliferation
marker PCNA along with either Zns5 or GFP in an osteocalcin
reporter zebrafish line. Although little proliferation was observed in
uncut fins, Zns5-positive BLSs noticeably proliferated in the
proximity of the amputation plane at 24 hpa. Moreover, within Zns5-
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Fig. 6. osteocalcin-positive scleroblasts at the blastema start to
express de novo osterix, an early marker for skeletal
differentiation. (A-C)osterix- and osteocalcin-reporter expression in
double Tg(osterix:mCherry; osteocalcin:GFP) fins. (A)Uncut fin. (B)24
hpa fin. (C)48 hpa fin. In B and C the arrows indicate cells co
expressing osterix and osteocalcin. Each image is a projection of several
confocal optical slices. (D)Percentage of double-positive, osterix- and
osteocalcin-expressing cells over the total of osteocalcin-expressing cells
in the blastema population. There was a significant increase at 48 hpa
compared with the uncut and 24 hpa samples (Student’s t-test, P<0.05;












positive BLSs there was a subpopulation of osteocalcin-expressing
BLSs that acquired a proliferative state, which has not previously
been reported. This is very pertinent because, in general,
differentiated cells rarely proliferate in their normal environment
(Kawakami, 2009; Wagers and Weissman, 2004).
The proliferation of scleroblasts near the amputation plane
suggests that they increase in number to feed the blastema. Next, we
investigated whether these cells also acquire a migratory phenotype
because the onset of the proliferative stage of regeneration has been
proposed to be coincident with the onset of cell migration (Gardiner
et al., 1996). To assess cell migration in vivo, we used a Cre-loxP
cell tracing strategy, which revealed that osteocalcin-expressing
scleroblasts near the amputation site detach from the internal surface
of lepidotrichia to migrate distally and integrate with the proliferative
pool of blastemal cells (Fig. 7). Indeed, the shape of these cells
change from being elongated, squeezed and flat to rounded, which
is the more usual form of migratory cells. We also show that
osteocalcin-expressing BLSs start migrating into the blastema at ~19
hpa, making up ~10% of the blastema cell pool. A consequence of
this migration is that the number of mature scleroblasts at the bone
lining near the stump is reduced after 24 hpa. Taking into account the
reacquisition of proliferative capacity by the osteocalcin BLSs, their
shape changes and their migration, we can conclude that these cells
contribute to the regenerating blastema. This conclusion differs
fundamentally from the commonly accepted view, in which other
mesenchymal cells from within the bony ray re-enter the cell cycle
and migrate distally to produce the blastema.
From 24 hpa onwards the number of osteocalcin-expressing
cells at the blastema decreases, probably as a consequence of the
gradual reduction in expression of this gene. The downregulation
of osteocalcin, a late bone differentiation marker, together with the
re-expression of an early marker, osterix indicates that osteocalcin-
expressing cells dedifferentiate during the process of integration
into the blastema. Dedifferentiation, defined as the cellular process
by which a mature differentiated cell can revert to a progenitor state
and re-express early marker genes, has been implicated in many
aspects of urodele regeneration, including limb and tail
regeneration (for a review, see Tanaka, 2003). In addition, it was
recently reported that during zebrafish heart regeneration pre-
existing cardiomyocytes also undergo dedifferentiation (Jopling et
al., 2010; Kikuchi et al., 2010).
The fate of osteocalcin-expressing cells after dedifferentiation and
integration into the blastema is difficult to assess in our experimental
conditions because they downregulate osteocalcin:GFP and lose the
yellow labelling in the blastema. It is possible that these cells
redifferentiate into scleroblasts in light of the data reported by Kragl
et al. who show, in urodeles, that cells redifferentiate to their original
lineage (Kragl et al., 2009). Indeed, the blastema is enriched in
differentiation and patterning signals that are known to be involved
in bone tissue specification, such as FGF, BMPs and Shh (Smith et
al., 2008; Lee et al., 2009; Laforest et al., 1998; Poss et al., 2000;
Quint et al., 2002), which are secreted by the basal layer of the
epidermis. Moreover, we report that dedifferentiated cells re-express
an early osteoblast marker, osterix and in these cells we did not find
coexpression with Msxb, a transcription factor implicated in the
maintenance of undifferentiated cells (Odelberg et al., 2000; Song et
al., 1992; Nechiporuk and Keating, 2002; Simon et al., 1995). This
suggests that these cells probably are not reverting back to an
embryonic or stem-like state but to a tissue-specific progenitor state.
However, we cannot exclude the possibility that we did not detect
any colocalization with Msxb because by this time-point osteocalcin
is being downregulated.
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Altogether, we show that, at 24 hpa of the zebrafish caudal fin,
differentiated scleroblasts arising from the stump proliferate,
change their shape, migrate and dedifferentiate to contribute to the
blastema population. Our study suggests conservation of
epimorphic regeneration mechanisms among vertebrates, and
demonstrates for the first time in vivo that migration and
dedifferentiation of mature cells is an important mechanism for
blastema formation in vertebrate regeneration.
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